

Oncology
Mark Fleming, MD
Chief, Boston Children's Hospital; Professor of Pathology, Harvard Medical School
Dr. Mark Daniel Fleming is Pathologist-in-Chief at Boston Children's Hospital. He specializes in Iron Metabolism, Sideroblastic Anemia, Hematopathology, Lymphoma, Myelodysplastic Syndrome, and Leukemia. He received his medical education from Harvard Medical School and completed his training at Brigham and Women's Hospital and Boston Children's Hospital. Dr. Fleming serves as an expert for the Department of Pathology for BCH's Precision Medicine Service.
Is Dr. Fleming right for you?
We'll build a personalized evaluation of Dr. Fleming for your case, side-by-side against the top alternatives in their subspecialty.
- In-depth evaluation of Dr. Fleming for your specific case
- Side-by-side comparison vs. the top alternatives
Fully credited toward membership if you join within 30 days
$25
Credentials
Board Certifications
- Anatomic Pathology
- Hematopathology
Education & Training
- Brigham and Women's Hospital, Anatomic Pathology (Residency)
- Brigham and Women's Hospital, Senior Resident, Surgical Pathology (Residency)
- Boston Children's Hospital, Hematology/Oncology (Fellowship)
- Brigham and Women's Hospital, Hematopathology (Fellowship)
Years in Practice
30+ years
Peer Recognition
- Healthgrades — Healthgrades Honor Roll
Clinical Focus
Subspecialties
Conditions & Treatments
Insurance(s) Accepted
Please verify your coverage with the provider — plan participation can change.
Practice Details
Hospital Affiliations
- Dana-Farber Cancer Institute
- Beth Israel Deaconess Hospital Plymouth
- Boston Children's Hospital
Conditions Dr. Fleming treats
Insurance accepted
Frequently asked
Does Dr. Fleming accept Curative insurance?
Where does Dr. Fleming practice?
What does Dr. Fleming specialize in?
How long has Dr. Fleming been practicing?
What is Dr. Fleming's medical training?
Specialists similar to Dr. Fleming
More breast oncology specialists in Massachusetts











